<qa>  What is the metabolic syndrome of insulin resistance, hyperinsulinemia, dyslipidemia and abdominalSchizophrenia is associated with increased rates of obesity, hyperglycemia, dyslipidemia and type 2 diabetes mellitus T2DM, causing increased morbidity and mortality due to acute e.g., diabetic ketoacidosis and long-term e.g., vascular disease complications.1-5As a result, cardiovascular CV mortality remains one of the leading causes of excess mortality in patients with psychotic disorders.6,7 T2DM is characterized by disturbances in insulin secretion and insulin action at skeletal muscle i.e., decreased glucose disposal, liver i.e., increased glucose production and adipose tissue i.e., increased lipolysis, leading to disturbances in glucose and lipid metabolism. The metabolic syndrome of insulin resistance, hyperinsulinemia, dyslipidemia and abdominal adiposity usually includes a procoagulant state and endothelial dysfunction, and is strongly associated with increased CV morbidity and mortality. 